Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionClark Capital Management Group, Inc.
Latest Disclosed Ownership1,449 shares
Latest Disclosed Value $ 509,961
Clark Capital Management Group, Inc. reports 9.19% increase in ownership of AMGN / Amgen Inc.

On May 15, 2026 - Clark Capital Management Group, Inc. filed a 13F-HR form disclosing ownership of 1,449 shares of Amgen Inc. (US:AMGN) valued at $509,831 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,327 shares of Amgen Inc.. This represents a change in shares of 9.19% during the quarter. The current value of the position is $506,541 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMGEN COM 031162100 1,449 122 9.19 510 17.28 0.0031
2026-02-17 2025-12-31 13F AMGEN COM 031162100 1,327 224 20.31 434 39.55 0.0027
2025-11-14 2025-09-30 13F AMGEN COM 031162100 1,103 182 19.76 311 21.01 0.0019
2025-08-14 2025-06-30 13F AMGEN COM 031162100 921 -87 -8.63 257 -17.89 0.0018
2025-05-15 2025-03-31 13F AMGEN COM 031162100 1,008 -255 -20.19 314 -4.86 0.0023
2025-02-14 2024-12-31 13F AMGEN COM 031162100 1,263 -121,340 -98.97 329 -99.17 0.0023
2024-11-14 2024-09-30 13F AMGEN COM 031162100 122,603 2,362 1.96 39,504 5.15 0.2705
2024-08-14 2024-06-30 13F AMGEN COM 031162100 120,241 1,838 1.55 37,569 11.60 0.2761
2024-05-15 2024-03-31 13F AMGEN COM 031162100 118,403 -90,535 -43.33 33,664 -44.06 0.2508
2024-02-14 2023-12-31 13F AMGEN COM 031162100 208,938 208,938 60,179 0.4926
2021-01-26 2020-12-31 13F AMGEN COM 031162100 0 -71,755 -100.00 0 -100.00
2020-11-12 2020-09-30 13F AMGEN COM 031162100 71,755 -3,395 -4.52 18,237 2.89 0.3437
2020-08-14 2020-06-30 13F AMGEN COM 031162100 75,150 -1,224 -1.60 17,725 14.48 0.3314
2020-05-15 2020-03-31 13F AMGEN COM 031162100 76,374 -28,524 -27.19 15,483 -38.77 0.3938
2020-01-27 2019-12-31 13F AMGEN COM 031162100 104,898 -2,073 -1.94 25,288 22.16 0.5299
2019-11-06 2019-09-30 13F AMGEN COM 031162100 106,971 881 0.83 20,700 5.88 0.4697
2019-07-12 2019-06-30 13F AMGEN COM 031162100 106,090 6,764 6.81 19,550 3.60 0.4127
2019-05-08 2019-03-31 13F AMGEN COM 031162100 99,326 -78,721 -44.21 18,870 -45.56 0.4500
2019-02-14 2018-12-31 13F AMGEN COM 031162100 178,047 -40,277 -18.45 34,660 -23.41 0.9327
2019-05-08 2018-09-30 13F/A-1 AMGEN COM 031162100 218,324 43,901 25.17 45,256 40.56 1.1460
2018-11-14 2018-09-30 13F AMGEN COM 031162100 218,424 43,799 45,277
2019-05-08 2018-06-30 13F/A-1 AMGEN COM 031162100 174,423 12,674 7.84 32,197 16.76 0.9265
2018-08-14 2018-06-30 13F AMGEN COM 031162100 174,625 12,876 32,234
2019-05-08 2018-03-31 13F/A-1 AMGEN COM 031162100 161,749 45,642 39.31 27,575 36.57 0.8640
2018-05-15 2018-03-31 13F AMGEN COM 031162100 161,785 45,678 27,581
2018-02-14 2017-12-31 13F AMGEN COM 031162100 116,107 -24,621 -17.50 20,191 -23.05 0.6172
2017-11-14 2017-09-30 13F AMGEN COM 031162100 140,728 36,865 35.49 26,239 46.68 0.8842
2017-08-14 2017-06-30 13F AMGEN COM 031162100 103,863 11,192 12.08 17,888 17.65 0.6954
2017-05-11 2017-03-31 13F AMGEN COM 031162100 92,671 -63,821 -40.78 15,205 -33.55 0.6743
2017-02-08 2016-12-31 13F AMGEN COM 031162100 156,492 19,831 14.51 22,881 0.37 1.1893
2016-11-14 2016-09-30 13F AMGEN COM 031162100 136,661 12,399 9.98 22,796 20.58 1.3081
2016-08-15 2016-06-30 13F AMGEN COM 031162100 124,262 22,286 21.85 18,906 23.66 1.2230
2016-05-16 2016-03-31 13F AMGEN COM 031162100 101,976 40,718 66.47 15,289 53.75 1.1837
2016-02-16 2015-12-31 13F AMGEN COM 031162100 61,258 5,801 10.46 9,944 29.63 0.8063
2015-11-03 2015-09-30 13F AMGEN COM 031162100 55,457 -10,034 -15.32 7,671 -23.70 0.6841
2015-08-10 2015-06-30 13F AMGEN COM 031162100 65,491 1,019 1.58 10,054 -2.45 0.9198
2015-05-07 2015-03-31 13F AMGEN COM 031162100 64,472 5,636 9.58 10,306 9.97 0.9364
2015-02-17 2014-12-31 13F AMGEN COM 031162100 58,836 4,196 7.68 9,372 22.11 0.8571
2014-11-13 2014-09-30 13F AMGEN COM 031162100 54,640 2,223 4.24 7,675 23.69 0.6641
2014-08-04 2014-06-30 13F AMGEN Common Stock 031162100 52,417 -3,436 -6.15 6,205 -9.93 0.5165
2014-05-13 2014-03-31 13F AMGEN COM 031162100 55,853 43,920 368.05 6,889 406.17 0.5932
2014-02-06 2013-12-31 13F AMGEN COM 031162100 11,933 -580 -4.64 1,361 -2.86 0.1130
2013-11-08 2013-09-30 13F AMGEN Common Stock 031162100 12,513 -7,101 -36.20 1,401 -27.60 0.1108
2013-08-08 2013-06-30 13F AMGEN Common Stock 031162100 19,614 19,614 1,935 0.1782
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.